Amedisys inc (AMED)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07
Cash Flows from Operating Activities:
Net income

127,907

120,129

30,683

37,631

-2,312

13,089

-97,775

-98,583

-382,342

113,273

136,223

86,613

65,118

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization

18,428

13,261

17,123

19,678

20,036

28,347

37,383

40,059

39,559

34,589

28,312

20,406

13,749

Provision for doubtful accounts

-

-

-

-

14,053

16,369

16,461

21,728

13,708

19,214

20,178

23,998

11,975

Non-cash compensation

25,000

17,900

16,300

16,401

11,824

5,597

6,519

7,217

8,292

10,634

7,848

6,372

3,188

401(k) employer match

10,509

8,976

8,754

6,875

6,089

6,216

7,998

10,013

7,550

22,762

19,083

12,384

6,605

Amortization and impairment of operating lease right of use assets

35,905

0

0

-

-

-

-

-

-

-

-

-

-

Write-off of investment

-

-

-

196

0

0

-

-

-

-

-

-

-

Loss (gain) on disposal of property and equipment

-141

-714

0

-582

-775

-4,592

-2,742

-1,471

-2,440

-3,236

-822

-673

-339

Gain on sale of care centers

-

-

-

-

184

2,967

1,752

0

0

-

-

-

-

Deferred income taxes

13,500

20,300

52,200

24,500

-677

22,561

-57,095

-31,161

-122,402

25,927

21,547

29,436

2,529

Equity in earnings from equity method investments

5,338

7,692

3,381

5,588

9,823

2,991

1,520

1,695

1,494

3,016

2,343

890

122

Amortization of deferred debt issuance costs/debt discount

873

797

735

740

959

797

699

1,442

1,576

1,576

1,576

1,207

25

Write off of deferred debt issuance costs

-

-

-

-

2,512

488

121

573

0

-

-

406

0

Return on equity investment

4,955

6,158

5,321

4,323

5,610

2,025

1,650

1,575

1,638

1,765

-980

-337

0

Asset impairment charge

1,500

0

1,300

4,432

77,268

3,107

9,492

162,103

579,955

-

-

-

-

Changes in operating assets and liabilities, net of impact of acquisitions:
Gain on release of Alliance's net liabilities (see Note 9)

-

-

-

-

-

-

-

-

-

-

-

-

4,212

Patient accounts receivable

24,146

-12,224

34,672

36,000

36,493

5,290

-41,578

42,840

6,526

10,494

-5,200

60,478

32,013

Other current assets

2,682

-8,679

4,940

-4,231

-6,455

6,269

501

-10,622

2,033

-1,981

14,996

4,095

-2,766

Other assets

-832

-2,947

12,749

11,415

3,523

-1,694

1,596

927

258

2,387

-2,327

-228

-1,484

Accounts payable

-11,329

3,165

-2,843

3,970

7,639

-3,168

-9,876

8,072

-1,521

4,606

1,674

-11,124

-1,089

U.S. Department of Justice settlement

-

-

-

-

-

-150,000

150,000

-

0

-

-

-

-

Accrued expenses

42,096

13,524

31,843

-7,618

8,406

3,495

-6,104

-19,994

5,049

-17,813

16,505

45,378

22,666

Other long-term obligations

-329

2,443

61

-726

-829

-3,226

3,839

-181

-1,981

420

2,723

-110

293

Operating lease liabilities

-32,295

0

0

-

-

-

-

-

-

-

-

-

-

Operating lease right of use assets

-3,503

0

0

-

-

-

-

-

-

-

-

-

-

Obligations due Medicare

-

-

-

-

-

-

-

-

-

-

-

-

-216

Net cash provided by operating activities

202,000

223,483

105,731

62,259

107,785

-65,534

102,263

69,494

141,210

206,273

247,659

150,741

93,085

Cash Flows from Investing Activities:
Purchases of short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

89,000

Proceeds from sales of short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

89,000

Proceeds from sale of deferred compensation plan assets

448

715

622

230

1,229

11

128

312

985

2,592

956

600

697

Proceeds from the sale of property and equipment

162

54

249

0

20,000

3

1,809

631

0

49

41

32

3,140

Withdrawals from restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

4,797

Purchases of deferred compensation plan assets

-

-

-

-

19

132

111

175

545

1,089

3,107

1,849

2,028

Purchases of property and equipment

7,888

6,558

10,707

15,717

21,429

12,008

41,736

48,262

44,415

63,971

36,359

28,385

28,633

Investments in equity method investees

210

7,144

476

1,040

3,485

6,407

10,067

0

4,500

5,000

-

-

-

Proceeds from sale of investment

-

-

-

-

5,000

0

0

-

-

-

-

-

-

Acquisitions of businesses, net of cash acquired

345,460

9,260

33,715

35,522

69,130

0

1,627

12,499

132,235

3,821

53,572

471,319

102,297

Proceeds from disposition of care centers

-

-

-

-

413

4,233

5,146

0

0

-

-

-

-

Acquisitions of reacquired franchise rights

-

-

-

-

-

-

-

-

-

2,376

5,214

4,730

0

Net cash used in investing activities

-352,948

-22,193

-44,027

-52,049

-67,421

-14,300

-46,458

-59,993

-180,710

-73,616

-97,255

-505,651

-124,324

Cash Flows from Financing Activities:
Outstanding checks in excess of bank balance

-

-

-

-

-

-

-

-

-

-

-4,548

4,548

0

Proceeds from issuance of stock upon exercise of stock options

3,611

5,953

4,554

0

399

564

261

156

245

1,501

3,772

2,848

3,840

Proceeds from issuance of stock to employee stock purchase plan

3,187

2,429

2,382

2,483

2,204

2,433

3,181

3,913

5,149

6,204

5,342

3,806

2,487

Shares withheld upon stock vesting

9,556

6,570

6,939

0

0

-

-

-

-

-

-

-

-

Tax benefit from stock options exercised and restricted stock vesting

-

-

-

7,241

2,073

0

57

0

0

2,386

1,506

2,909

2,129

Noncontrolling interest distribution

1,062

1,090

216

329

436

0

163

323

700

304

-

-

-

Proceeds from borrowings under term loan

175,000

0

0

-

-

-

-

-

-

-

-

-

-

Proceeds from borrowings under revolving line of credit

262,500

138,000

0

134,500

63,400

241,800

25,500

0

0

-

-

-

-

Repayments of borrowings under revolving line of credit

200,000

130,500

0

134,500

78,400

226,800

25,500

0

0

-

130,700

153,700

0

Proceeds from issuance of long-term obligations

-

-

-

-

100,000

68,250

0

60,000

0

-

-

250,000

0

Principal payments of long-term obligations

5,624

91,450

5,319

5,000

103,000

13,904

55,807

104,441

37,485

44,838

44,338

34,920

4,775

Debt issuance costs

800

2,433

0

0

2,553

1,780

576

2,265

0

-

-

8,124

473

Proceeds from revolving line of credit

-

-

-

-

-

-

-

-

-

-

50,200

234,200

0

Purchase of company stock

0

181,402

0

12,300

4,581

0

0

-

-

11,796

-

-

-

Assets contributed to equity investment

-

-

-

405

0

0

-

-

-

-

-

-

-

Repurchase of noncontrolling interest

0

361

0

0

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

227,209

-267,424

-5,538

-7,515

-20,894

70,563

-53,047

-42,960

-32,791

-46,847

-118,766

301,567

3,208

Net increase (decrease) in cash, cash equivalents and restricted cash

76,261

-66,134

56,166

2,695

19,470

-9,271

2,758

-33,459

-72,291

85,810

31,638

-53,343

-28,031

Supplemental Disclosures of Cash Flow Information:
Cash paid for interest

9,628

3,522

2,697

2,897

6,175

7,602

3,990

7,779

7,340

8,339

10,339

12,950

507

Cash paid for income taxes, net of refunds received

29,522

14,278

315

755

-12,185

-1,766

3,385

2,945

11,655

50,765

68,635

20,138

26,105

Supplemental Disclosures of Non-Cash Financing Activities:
Note payable issued for software licenses

0

418

0

0

-

-

-

-

-

-

-

-

-

Capital leases

-

-

-

0

-

-

-

-

-

-

-

-

-

Notes payable issued for/assumed in acquisitions

-

-

-

-

-

-

-

-

1,058

750

9,455

-

-

Notes payable issued for software licenses

-

-

-

-

-

-

-

2,214

0

10,801

1,463

2,126

5,501

(Sale) acquistion of noncontrolling interests

-

-

-

-

-

-1,549

145

15,931

0

300

-

-

-